Research progress in diagnosis and assessment of sarcopenia

WU Xuliang; LI Yifei; ZHAO Yongfang

doi:10.16306/j.1008-861x.2024.03.014

您当前的位置：

首页 >

文章列表页 >

Research progress in diagnosis and assessment of sarcopenia

Review | 更新时间：2024-05-31

- Research progress in diagnosis and assessment of sarcopenia
- Academic Journal of Shanghai University of Traditional Chinese Medicine Vol. 38, Issue 3, Pages: 93-100(2024)
- 作者机构：
  
  1.上海中医药大学附属曙光医院（上海　201203）
  2.上海中医药大学（上海　201203）
  3.上海市中医药研究院骨伤科研究所（上海　201203）
- 作者简介：
- 基金信息：
- DOI：10.16306/j.1008-861x.2024.03.014
  CLC：
- Published：25 May 2024，
  
  Received：28 October 2023，
  
  Revised：23 January 2024，
扫描看全文
吴煦亮,李一飞,赵咏芳.肌少症诊断及评估方法研究进展[J].上海中医药大学学报,2024,38(03):93-100.

WU Xuliang,LI Yifei,ZHAO Yongfang.Research progress in diagnosis and assessment of sarcopenia[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2024,38(03):93-100.
吴煦亮,李一飞,赵咏芳.肌少症诊断及评估方法研究进展[J].上海中医药大学学报,2024,38(03):93-100. DOI： 10.16306/j.1008-861x.2024.03.014.

WU Xuliang,LI Yifei,ZHAO Yongfang.Research progress in diagnosis and assessment of sarcopenia[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2024,38(03):93-100. DOI： 10.16306/j.1008-861x.2024.03.014.

摘要

肌少症是一种随年龄增加而逐渐出现的骨骼肌体积和数量减少、功能下降的疾病，常导致跌倒、骨折甚至死亡等不良后果。随着中国社会老龄化进程的加速，肌少症的患病率逐年升高，故重视肌少症的诊断与评估、积极寻找合适的干预手段具有重要的现实意义。收集全球范围内肌少症的相关诊疗指南或共识，系统阐述肌少症的概念、诊断要素、流行病学、危险因素及中医药防治进展等，为临床肌少症的诊断与治疗提供参考依据。

Abstract

Sarcopenia is a disease with skeletal muscle volume and number reducing and function declining gradually with age， and it often leads to adverse consequences such as falls， fractures， even death. With the acceleration of the aging process of Chinese society， the prevalence of sarcopenia is increasing year by year，so it is of great practical significance to pay attention to the diagnosis and evaluation of sarcopenia and actively look for appropriate intervention means. This paper collects the global guidelines and consensus on sarcopenia diagnosis and treatment， systematically elaborates the concept， diagnostic elements， epidemiology， risk factors， and traditional Chinese medicine prevention and treatment progress of sarcopenia， in order to provide the references for the diagnosis and treatment of sarcopenia in clinic.

关键词

肌少症概念诊断评估工具综述

Keywords

sarcopeniaconceptdiagnosisassessment toolreview

references

丛明华. Sarcopenia还是myopenia？［J］. 肿瘤代谢与营养电子杂志， 2014， 1（1）： 30-32.

CONG M H. Sarcopenia or myopenia？［J］. Electronic Journal of Metabolism and Nutrition of Cancer， 2014， 1（1）： 30-32.

LIMA A B， BAPTISTA F， HENRINQUES-NETO D， et al. Symptoms of Sarcopenia and Physical Fitness through the Senior Fitness Test［J］. Int J Environ Res Public Health， 2023， 20（3）： 2711.

JIN H， XIE W， HE M， et al. Pyroptosis and Sarcopenia： Frontier Perspective of Disease Mechanism［J］. Cells， 2022， 11（7）： 1078.

YAMADA M， ARAI H. Implication of Exercise for Healthy Longevity in Older People［J］. Top Geria Rehab， 2022， 38（2）： 95-100.

MELLEN R H， GIROTTO O S， MARQUES E B， et al. Insights into Pathogenesis， Nutritional and Drug Approach in Sarcopenia： A Systematic Review［J］. Biomedicines， 2023， 11（1）： 136.

SHIGEHARA K， KATO Y， IZUMI K， et al. Relationship between Testosterone and Sarcopenia in Older-Adult Men： A Narrative Review［J］. J Clin Med， 2022， 11（20）： 6202.

刘娟，丁清清，周白瑜，等. 中国老年人肌少症诊疗专家共识（2021）［J］. 中华老年医学杂志， 2021， 40（8）： 943-952.

LIU J， DING Q Q， ZHOU B Y， et al. Chinese expert consensus on diagnosis and treatment for elderly with sarcopenia （2021）［J］. Chinese Journal of Geriatrics， 2021， 40（8）： 943-952.

CAMARGO PEREIRA C， PAGOTTO V， DE OLIVEIRA C， et al. Low muscle mass and mortality risk later in life： A 10-year follow-up study［J］. PLoS one，2022，17（7）： e0271579.

JYVÄKORPI S K， LINDSTRÖM M， SUOMINEN M H， et al. Relationship between frailty， nutrition， body composition， quality of life， and gender in institutionalized older people［J］. Aging Clin Exp Res， 2022， 34（6）： 1357-1363.

杜雅琼，曹越月. 我国健康养老概念认知透视：一个文献综述［J］. 沈阳师范大学学报（社会科学版）， 2023， 47（2）： 105-112.

DU Y Q， CAO Y Y. A Cognitive Perspective of the Concept of Healthy Elderly Care in China： A Literature Review［J］. Journal of Shenyang Normal University （Social Science Edition）， 2023， 47（2）： 105-112.

CRUZ-JENTOFT A J， BAEYENS J P， BAUER J M， et al. Sarcopenia： European consensus on definition and diagnosis： Report of the European Working Group on Sarcopenia in Older People［J］. Age Ageing， 2010，39（4）： 412-423.

CRUZ-JENTOFT A J， BAHAT G， BAUER J， et al. Sarcopenia： revised European consensus on definition and diagnosis［J］. Age Ageing， 2019， 48（4）： 601.

DENT E， MORLEY J E， CRUZ-JENTOFT A J， et al. International Clinical Practice Guidelines for Sarcopenia （ICFSR）： Screening， Diagnosis and Management［J］. J Nutr Health Aging， 2018， 22（10）： 1148-1161.

CHEN L K， WOO J， ASSANTACHAI P， et al. Asian Working Group for Sarcopenia： 2019 Consensus Update on Sarcopenia Diagnosis and Treatment［J］. J Am Med Dir Assoc， 2020， 21（3）： 300-307.

CHEN L K， LIU L K， WOO J， et al. Sarcopenia in Asia： consensus report of the Asian Working Group for Sarcopenia［J］. J Am Med Dir Assoc， 2014， 15（2）： 95-101.

TANAKA T， TAKAHASHI K， AKISHITA M， et al. "Yubi-wakka" （finger-ring） test： A practical self-screening method for sarcopenia， and a predictor of disability and mortality among Japanese community-dwelling older adults［J］. Geriatr Gerontol Int， 2018， 18（2）： 224-232.

ISHII S， TANAKA T， SHIBASAKI K， et al. Development of a simple screening test for sarcopenia in older adults［J］. Geriatr Gerontol Int， 2014， 14（ Suppl1）： 93-101.

LIM W S， CHEONG C Y， LIM J P， et al. Singapore Clinical Practice Guidelines For Sarcopenia： Screening， Diagnosis， Management and Prevention［J］. J Frailty Aging， 2022， 11（4）： 348-369.

CUI H， WANG Z H， WU J， et al. Chinese expert consensus on prevention and intervention for elderly with sarcopenia （2023）［J］. Aging Med （Milton）， 2023， 6（2）： 104-115.

中华医学会骨质疏松和骨矿盐疾病分会. 肌少症共识［J］. 中华骨质疏松和骨矿盐疾病杂志， 2016， 9（3）： 215-227.

Osteoporosis and Bone Mineral Salt Disease Branch， Chinese Medical Association. Sarcopenia Consensus［J］. Chinese Journal of Osteoporosis and Bone Mineral Research， 2016， 9（3）： 215-227.

陈湘君. 中医内科学［M］. 上海：上海科学技术出版社， 2013： 331， 450.

CHEN X J. Traditional Chinese Internal Medicine［M］. Shanghai： Shanghai Scientific and Technical Publishers， 2013： 331， 450.

王泽平，陈可冀，刘龙涛. 肌肉衰减综合征及中医药防治进展［J］. 中国中西医结合杂志， 2020， 40（9）： 1117-1120.

WANG Z P， CHEN K J， LIU L T. Sarcopenia and TCM Prevention and Treatment Progress［J］. Chinese Journal of Integrated Traditional and Western Medicine， 2020， 40（9）： 1117-1120.

孙帅帅，张立，张泽，等. 从脾肾论治老年肌少症［J］. 中国中医药现代远程教育， 2021， 19（4）： 138-140.

SUN S S， ZHANG L， ZHANG Z， et al. Treatment of Sarcopenia from Spleen and Kidney［J］. Chinese Medicine Modern Distance Education of China， 2021， 19（4）： 138-140.

魏静，魏凯善，罗敏，等. 从“脾”论治肌肉减少症［J］. 中医药临床杂志， 2019， 31（7）： 1282-1284.

WEI J， WEI K S， LUO M， et al. Treating Sarcopenia on the Basis of Spleen［J］. Clinical Journal of Traditional Chinese Medicine， 2019， 31（7）： 1282-1284.

代菊红. 老年骨骼肌减少症的中医证型及运用SARC-Calf量表评估的积分分布［D］. 天津：天津中医药大学， 2021.

DAI J H. TCM Syndrome Types of Sarcopenia in the Elderly and the Distribution of Points Assessed Using the SARC-Calf Scale［D］. Tianjin： Tianjin University of Traditional Chinese Medicine， 2021.

王吴娇. 老年住院患者肌少症中医证型及相关因素研究［D］. 南京：南京中医药大学， 2020.

WANG W J. Study about the TCM Syndrome Types and Relative Factors of Sarcopenia in Elderly Inpatients［D］. Nanjing： Nanjing University of Chinese Medicine， 2020.

刘亚楠. 衡先培教授辨治肌少症经验［J］. 福建中医药， 2016， 47（4）： 53-54.

LIU Y N. Professor Heng Xianpei's experience of Treating Sarcopenia［J］. Fujian Journal of Traditional Chinese Medicine， 2016， 47（4）： 53-54.

CRUZ-JENTOFT A J， SAYER A A. Sarcopenia［J］. Lancet，2019，393（10191）： 2636-2646.

MAYHEW A J， AMOG K， PHILLIPS S， et al. The prevalence of sarcopenia in community-dwelling older adults， an exploration of differences between studies and within definitions： a systematic review and meta-analyses［J］. Age Aging， 2019， 48（1）： 48-56.

REN X， ZHANG X， HE Q， et al. Prevalence of sarcopenia in Chinese community-dwelling elderly： a systematic review［J］. BMC Public Health， 2022， 22（1）： 1702.

XIN C， SUN X， LU L， et al. Prevalence of sarcopenia in older Chinese adults： a systematic review and meta-analysis［J］. BMJ Open， 2021， 11（8）： e041879.

GAO Q， HU K， YAN C， et al. Associated Factors of Sarcopenia in Community-Dwelling Older Adults： A Systematic Review and Meta-Analysis［J］. Nutrients， 2021， 13（12）： 4291.

KAGA H， TAMURA Y， SOMEYA Y， et al. Prediabetes is an independent risk factor for sarcopenia in older men， but not in older women： the Bunkyo Health Study［J］. J Cachexia Sarcopenia Muscle， 2022， 13（6）： 2835-2842.

QIU S， CAI X， SUN Z， et al. Comment on 'Prediabetes is an independent risk factor for sarcopenia in older men， but not in older women： the Bunkyo Health Study' by Kaga et al［J］. J Cachexia Sarcopenia Muscle， 2023， 14（5）： 2452-2453.

张艳，谈玉婷，黄夕夏，等. 上海市社区老年人肌少症患病率及相关危险因素分析［J］. 老年医学与保健， 2018， 24（6）： 608-613.

ZHANG Y， TAN Y T， HUANG X X， et al. Prevalence of Sarcopenia and the Associated Risk Factors in Community Elderly in Shanghai［J］. Geriatrics & Health Care， 2018， 24（6）： 608-613.

王光辉，蔡文玮，沈晓君，等. 欧洲肌少症共识在上海部分社区老年人群肌少症筛查中的应用［J］. 中国临床保健杂志， 2020， 23（3）： 325-330.

WANG G H， CAI W W， SHEN X J， et al. The application of EWGSOP2 consensus in the screening for sarcopenia in the elderly in Shanghai communities［J］. Chinese Journal of Clinical Healthcare， 2020， 23（3）： 325-330.

SKINNER J， SHEPSTONE L， HICKSON M， et al. Alcohol Consumption and Measures of Sarcopenic Muscle Risk： Cross-Sectional and Prospective Associations Within the UK Biobank Study［J］. Calcif Tissue Int， 2023， 113（2）： 143-156.

李小凯，丁劼，孙雯，等. 健脾方对废用性肌肉萎缩小鼠Akt/FOXO3a通路表达的机制研究［J］. 上海中医药大学学报， 2022， 36（5）： 86-92.

LI X K， DING J， SUN W， et al. Mechanism of Jianpi Formula on expression of Akt/FOXO3a pathway in disused muscle atrophy mice［J］. Academic Journal of Shanghai University of Traditional Chinese Medicine， 2022， 36（5）： 86-92.

孙雯，丁劼，王培歌，等. 密骨胶囊通过NF-κB和AKT-mTOR信号通路对肌少症的作用机制［J］. 中国骨质疏松杂志， 2023， 29（7）： 942-948.

SUN W， DING J， WANG P G， et al. Study on the mechanism of the Migu capsule in the treatment of sarcopenia via NF-κB and AKT-mTOR signaling pathway［J］. Chinese Journal of Osteoporosis， 2023， 29（7）： 942-948.

张英英，申晨，张颖，等. 以“总有效率”作为中医药疗效评价指标存在的误区［J］. 中国药物评价， 2020， 37（5）： 337-340.

ZHANG Y Y， SHEN C， ZHANG Y， et al. Misunderstandings in Using "Total Effective Rate" As an Index for Evaluating the Therapeutic Effect of Traditional Chinese Medicine［J］. Chinese Journal of Drug Evaluation， 2020， 37（5）： 337-340.

更多指标>

Views

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Modern research progress on mechanism of bone destruction and traditional Chinese medicine prevention and treatment in rheumatoid arthritis

Research progress on mechanisms of m⁶A RNA methylated modification regulating non⁃small cell lung cancer

Research progress on intervention of active components of traditional Chinese medicine on epithelial⁃mesenchymal transition of cervical cancer

Current status of traditional Chinese medicine and western medicine in diagnosis and treatment of pulmonary ground⁃glass nodule

Research progress of traditional Chinese medicine in treating diabetic kidney disease by regulating oxidative stress pathway

Related Author

XIANG Zheng

ZHANG Chengbo

HAN Haihui

WANG Jianye

QIU Guowei

SHEN Jun

XIE Jun

SUN Songtao

Related Institution

Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Institute of Arthritis of Integrative Medicine， Shanghai Academy of Traditional Chinese Medicine

The First Department of Oncology， Yueyang Hospital of Integrated Traditional Chinese and Western Medicine， Shanghai University of Traditional Chinese Medicine

Heilongjiang University of Traditional Chinese Medicine

The Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine

⁰